StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Aravive Inc. (ARAV) Extends Gain, Up 250%
November 20, 2019 7:43 AM
Aravive Inc ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Momentum Movers
Trader Talk
Next Articles
Aravive Inc. (ARAV) PT Raised to $31 at H.C. Wainwright
November 20, 2019 12:14 PM
Aravive Inc. (ARAV) Halted on LUDP
November 20, 2019 9:46 AM
Aravive Inc. (ARAV) Climbs 80% After Positive Data from Ongoing Trial of AVB-500 in Ovarian Cancer
November 20, 2019 7:21 AM
Form 8-K Aravive, Inc. For: Nov 20
November 20, 2019 7:07 AM
Aravive (ARAV) Reports Positive Data Supporting Relationship Between AVB-500 Levels, Anti-Tumor Activity and Progression Free Survival in Women with Ovarian Cancer
November 20, 2019 7:02 AM
Aravive Reports Positive Data Supporting Relationship Between AVB-500 Levels, Anti-Tumor Activity and Progression Free Survival in Women with Ovarian Cancer
November 20, 2019 7:00 AM
